163 related articles for article (PubMed ID: 19404541)
1. Venous thromboembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study.
Spencer FA; Gore JM; Reed G; Lessard D; Pacifico L; Emery C; Crowther MA; Goldberg RJ
Thromb Haemost; 2009 May; 101(5):878-85. PubMed ID: 19404541
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism in the elderly. A community-based perspective.
Spencer FA; Gore JM; Lessard D; Emery C; Pacifico L; Reed G; Gurwitz JH; Goldberg RJ
Thromb Haemost; 2008 Nov; 100(5):780-8. PubMed ID: 18989521
[TBL] [Abstract][Full Text] [Related]
3. Renal Impairment, Recurrent Venous Thromboembolism and Bleeding in Cancer Patients with Acute Venous Thromboembolism-Analysis of the CATCH Study.
Bauersachs R; Lee AYY; Kamphuisen PW; Meyer G; Janas MS; Jarner MF; Khorana AA;
Thromb Haemost; 2018 May; 118(5):914-921. PubMed ID: 29618162
[TBL] [Abstract][Full Text] [Related]
4. A high Gas6 level in plasma predicts venous thromboembolism recurrence, major bleeding and mortality in the elderly: a prospective multicenter cohort study.
Schnegg-Kaufmann A; Calzavarini S; Limacher A; Mean M; Righini M; Staub D; Beer JH; Frauchiger B; Osterwalder J; Kucher N; Matter CM; Husmann M; Banyai M; Aschwanden M; Mazzolai L; Hugli O; Nagler M; Daskalakis M; Rodondi N; Aujesky D; Angelillo-Scherrer A
J Thromb Haemost; 2019 Feb; 17(2):306-318. PubMed ID: 30570809
[TBL] [Abstract][Full Text] [Related]
5. Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009).
Huang W; Goldberg RJ; Cohen AT; Anderson FA; Kiefe CI; Gore JM; Spencer FA
Thromb Res; 2015 Jun; 135(6):1100-6. PubMed ID: 25921936
[TBL] [Abstract][Full Text] [Related]
6. Isolated calf deep vein thrombosis in the community setting: the Worcester Venous Thromboembolism study.
Spencer FA; Kroll A; Lessard D; Emery C; Glushchenko AV; Pacifico L; Reed G; Gore JM; Goldberg RJ
J Thromb Thrombolysis; 2012 Apr; 33(3):211-7. PubMed ID: 22261699
[TBL] [Abstract][Full Text] [Related]
7. Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study.
Spencer FA; Emery C; Joffe SW; Pacifico L; Lessard D; Reed G; Gore JM; Goldberg RJ
J Thromb Thrombolysis; 2009 Nov; 28(4):401-9. PubMed ID: 19629642
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism.
Reiner MF; Stivala S; Limacher A; Bonetti NR; Méan M; Egloff M; Rodondi N; Aujesky D; von Schacky C; Lüscher TF; Camici GG; Beer JH
J Thromb Haemost; 2017 Jan; 15(1):47-56. PubMed ID: 27790827
[TBL] [Abstract][Full Text] [Related]
9. Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR.
Sandén P; Renlund H; Svensson PJ; Själander A
Thromb Haemost; 2017 Jan; 117(1):27-32. PubMed ID: 27652593
[TBL] [Abstract][Full Text] [Related]
10. Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer.
Schulman S; Goldhaber SZ; Kearon C; Kakkar AK; Schellong S; Eriksson H; Hantel S; Feuring M; Kreuzer J
Thromb Haemost; 2015 Jul; 114(1):150-7. PubMed ID: 25739680
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
Coleman CI; Bunz TJ; Turpie AGG
Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE Registry.
Nieto JA; Camara T; Gonzalez-Higueras E; Ruiz-Gimenez N; Guijarro R; Marchena PJ; Monreal M;
Thromb Haemost; 2008 Nov; 100(5):789-96. PubMed ID: 18989522
[TBL] [Abstract][Full Text] [Related]
13. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism.
Carrier M; Le Gal G; Wells PS; Rodger MA
Ann Intern Med; 2010 May; 152(9):578-89. PubMed ID: 20439576
[TBL] [Abstract][Full Text] [Related]
14. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
[TBL] [Abstract][Full Text] [Related]
15. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review.
Wu C; Alotaibi GS; Alsaleh K; Sean McMurtry M
Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174
[TBL] [Abstract][Full Text] [Related]
16. Safety and effectiveness of rivaroxaban and apixaban in patients with venous thromboembolism: a nationwide study.
Sindet-Pedersen C; Staerk L; Pallisgaard JL; Gerds TA; Berger JS; Torp-Pedersen C; Gislason GH; Olesen JB
Eur Heart J Cardiovasc Pharmacother; 2018 Oct; 4(4):220-227. PubMed ID: 29945162
[TBL] [Abstract][Full Text] [Related]
17. The association of recurrence and bleeding events with mortality after venous thromboembolism: From the COMMAND VTE Registry.
Yamashita Y; Yoshikawa Y; Morimoto T; Amano H; Takase T; Hiramori S; Kim K; Oi M; Akao M; Kobayashi Y; Toyofuku M; Tada T; Chen PM; Murata K; Tsuyuki Y; Saga S; Sasa T; Sakamoto J; Kinoshita M; Togi K; Mabuchi H; Takabayashi K; Shiomi H; Kato T; Makiyama T; Ono K; Kimura T;
Int J Cardiol; 2019 Oct; 292():198-204. PubMed ID: 31239211
[TBL] [Abstract][Full Text] [Related]
18. No Difference Between Low- and Regular-dose Aspirin for Venous Thromboembolism Prophylaxis After THA.
Faour M; Piuzzi NS; Brigati DP; Klika AK; Mont MA; Barsoum WK; Higuera CA
Clin Orthop Relat Res; 2019 Feb; 477(2):396-402. PubMed ID: 30624322
[TBL] [Abstract][Full Text] [Related]
19. Methodological issues affecting estimates of bleeding risks and consequences after venous thromboembolism.
Glynn RJ
Thromb Haemost; 2009 May; 101(5):797-8. PubMed ID: 19404527
[No Abstract] [Full Text] [Related]
20. Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment.
Brown JD; Goodin AJ; Lip GYH; Adams VR
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29514808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
